Inactivation of PNKP by mutant ATXN3 triggers apoptosis by activating the DNA damage-response pathway in SCA3

Autor: Partha S. Sarkar, Tetsuo Ashizawa, Tohru Matsuura, Patrícia Maciel, Tapas K. Hazra, Hang L. Zhang, Adriana A. Paulucci-Holthauzen, Yongping Liu, Arpita Chatterjee, Arnulf H. Koeppen, Rui Gao, Sanjeev Choudhary, Anabela Silva-Fernandes, Xiang Fang
Přispěvatelé: Universidade do Minho
Jazyk: angličtina
Rok vydání: 2015
Předmět:
Cancer Research
congenital
hereditary
and neonatal diseases and abnormalities

DNA Repair
lcsh:QH426-470
DNA damage
DNA repair
Mutant
Medicina Básica [Ciências Médicas]
Apoptosis
Nerve Tissue Proteins
Ataxia Telangiectasia Mutated Proteins
Biology
Protein Aggregates
03 medical and health sciences
0302 clinical medicine
Genetics
medicine
Humans
Ataxin-3
Molecular Biology
Genetics (clinical)
Ecology
Evolution
Behavior and Systematics

030304 developmental biology
0303 health sciences
Science & Technology
Neurodegeneration
Nuclear Proteins
Machado-Joseph Disease
medicine.disease
Molecular biology
3. Good health
Repressor Proteins
Phosphotransferases (Alcohol Group Acceptor)
Protein Kinase C-delta
lcsh:Genetics
DNA Repair Enzymes
Perspective
Ciências Médicas::Medicina Básica
Spinocerebellar ataxia
Signal transduction
Trinucleotide Repeat Expansion
Trinucleotide repeat expansion
030217 neurology & neurosurgery
DNA Damage
Signal Transduction
Research Article
Zdroj: PLoS Genetics, Vol 11, Iss 1, p e1004834 (2015)
PLoS Genetics
Repositório Científico de Acesso Aberto de Portugal
Repositório Científico de Acesso Aberto de Portugal (RCAAP)
instacron:RCAAP
ISSN: 1553-7404
1553-7390
Popis: Spinocerebellar ataxia type 3 (SCA3), also known as Machado-Joseph disease (MJD), is an untreatable autosomal dominant neurodegenerative disease, and the most common such inherited ataxia worldwide. The mutation in SCA3 is the expansion of a polymorphic CAG tri-nucleotide repeat sequence in the C-terminal coding region of the ATXN3 gene at chromosomal locus 14q32.1. The mutant ATXN3 protein encoding expanded glutamine (polyQ) sequences interacts with multiple proteins in vivo, and is deposited as aggregates in the SCA3 brain. A large body of literature suggests that the loss of function of the native ATNX3-interacting proteins that are deposited in the polyQ aggregates contributes to cellular toxicity, systemic neurodegeneration and the pathogenic mechanism in SCA3. Nonetheless, a significant understanding of the disease etiology of SCA3, the molecular mechanism by which the polyQ expansions in the mutant ATXN3 induce neurodegeneration in SCA3 has remained elusive. In the present study, we show that the essential DNA strand break repair enzyme PNKP (polynucleotide kinase 3'-phosphatase) interacts with, and is inactivated by, the mutant ATXN3, resulting in inefficient DNA repair, persistent accumulation of DNA damage/strand breaks, and subsequent chronic activation of the DNA damage-response ataxia telangiectasia-mutated (ATM) signaling pathway in SCA3. We report that persistent accumulation of DNA damage/strand breaks and chronic activation of the serine/threonine kinase ATM and the downstream p53 and protein kinase C-d pro-apoptotic pathways trigger neuronal dysfunction and eventually neuronal death in SCA3. Either PNKP overexpression or pharmacological inhibition of ATM dramatically blocked mutant ATXN3-mediated cell death. Discovery of the mechanism by which mutant ATXN3 induces DNA damage and amplifies the pro-death signaling pathways provides a molecular basis for neurodegeneration due to PNKP inactivation in SCA3, and for the first time offers a possible approach to treatment.
This study was funded by NIH grant NS073976 to TKH and a John Sealy Grant to PSS.
Databáze: OpenAIRE